News

Neuronetics Set to Reveal Q4 2024 Results and Host Call

Neuronetics Set to Reveal Q4 2024 Results and Host Call

Neuronetics Plans Q4 2024 Financial Results Announcement

MALVERN, Pa. — Neuronetics, Inc. (NASDAQ: STIM), a trailblazer in medical technology, is gearing up to unveil its financial outcomes for the fourth quarter of 2024. The much-anticipated announcement is set for release before the market opens on a Tuesday. This is an exciting time for the company as investors look for insights into its financial health and operational efficiencies.

Details of the Conference Call

Following the announcement, Neuronetics will host a conference call at 8:30 a.m. Eastern Time on the same day. The call aims to provide stakeholders with a clear understanding of the company's performance and strategic direction. During this live session, the management team will discuss key results and answer questions, offering a platform for engaging dialogue with investors.

Understanding Neuronetics' Commitment to Mental Health

At the core of Neuronetics’ mission is the belief that mental health is paramount. The company is a recognized leader in neuroscience, dedicated to redefining how patients and healthcare providers view treatment options. Their flagship product, NeuroStar Advanced Therapy, stands out as a non-drug, noninvasive solution aimed at improving the quality of life for individuals with neurohealth disorders.

The NeuroStar Advanced Therapy Experience

NeuroStar is specifically indicated for treating major depressive disorder (MDD) and offers significant relief for patients who haven't responded satisfactorily to traditional medications. This innovative treatment technique not only targets depressive episodes but also helps mitigate anxiety symptoms in patients with comorbid conditions. Importantly, NeuroStar has received FDA clearance for use as an adjunct for adults with obsessive-compulsive disorder and is approved for use in adolescents ages 15-21 with MDD.

The Transformative Impact of NeuroStar

Neuronetics is proud to share that it has delivered over 6.9 million NeuroStar treatments, marking a significant contribution to the mental health landscape. This advanced therapy aligns with the company’s overall commitment to transforming lives through effective treatment modalities. As they continue to innovate, Neuronetics aims to surpass existing treatment expectations by offering solutions that yield extraordinary results.

Long-Term Vision of Neuronetics

The company's focus on patient-first initiatives drives its strategic decisions. Neuronetics thrives on its mission to not only provide treatments but also to foster an environment of hope for those struggling with mental health issues. This vision is rooted in a philosophy that collaborates with healthcare professionals to enhance the therapeutic experience.

Connecting with Neuronetics

Pursuing avenues to learn more about Neuronetics is highly encouraged. The company fosters open channels of communication with both investors and media representatives. Those interested in the latest updates can visit their website or reach out directly through designated contact points.

Investor Relations

For investor inquiries, Mike Vallie or Mark Klausner can be reached through ICR Healthcare at 443-213-0499 or via email at ir@neuronetics.com. Their accessibility reflects Neuronetics' commitment to transparency and engagement.

Media Relations

For media inquiries, EvolveMKD serves as the point of contact at 646-517-4220 or via email at NeuroStar@evolvemkd.com, further ensuring the company maintains a strong presence in the public discourse surrounding mental health innovations.

Frequently Asked Questions

When will Neuronetics release its Q4 2024 results?

Neuronetics plans to release its fourth quarter 2024 financial results prior to market open on a Tuesday.

How can I access the conference call?

Details for accessing the conference call will be provided alongside the financial results announcement, typically available on their official website.

What is NeuroStar Advanced Therapy?

NeuroStar is a non-invasive treatment that aims to help patients suffering from major depressive disorder and anxiety symptoms.

Who can benefit from NeuroStar treatment?

NeuroStar is intended for adults with major depressive disorder and can also benefit adolescents aged 15-21, particularly if traditional treatments have failed.

How can I learn more about Neuronetics’ offerings?

Further information can be found on Neuronetics' website or by contacting their investor relations and media representatives directly.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

LEOTEK's AI Tech Shaping Smarter Cities at COP31

Updated Category News Views 22

AI-Powered Evolution in Urban Infrastructure Hang on to your hats, folks, 'cause LEOTEK is turning heads at COP31 with its AI-driven transformation of urban landscapes. As cities stretch at the seams to keep up with modern challenges, LEOTEK's got more than a few tricks up its sleeve with its trademark blend of traffic system intelligence and energy management prowess....

Continue Reading
Fluence Energy Faces Class Action: Investor Insights

Updated Category News Views 21

Investor Blues: Fluence Under the Weather If you've been keeping an eye on Fluence Energy (NASDAQ:FLNC), you're probably clutching your metaphorical pearls right now. Here's the scoop: on November 2, 2026, the stock took another nosedive—dropping nearly 9%—as the company announced that both CEO Julian Nebreda and CFO Ahmad Pasha had packed their bags. A leadership...

Continue Reading
OI Investors Crack Down: Class Action Filing Looms

Updated Category News Views 53

O-I Glass Under Fire: The Glass Containers Giant Stumbles If you’ve been watching the ticker for O-I Glass, Inc. (NYSE:OI), you know it’s been a rocky road lately. We’re knee-deep in another saga of corporate promises meeting harsh reality. The novel here isn’t just the $1 trillion industry O-I Glass plays in, but the speed at which its fortunes seem to be...

Continue Reading
Finding the Right Auto Insurance: What to Consider

Updated Category News Views 33

Understanding the Basics of Auto Insurance Coverage Now, you might think the state knows best when it sets those minimum auto insurance requirements. But let's not kid ourselves—skimping on coverage can leave you high and dry if things go south on the road. That's where an expert voice like Corey Frazer's comes in, laying out why those limits often fall short. Minimum...

Continue Reading
CytoSorbents Hits Financial Milestone in Q3 2026

Updated Category News Views 52

CytoSorbents' Financial Turnaround Imagine the smell of fresh opportunity wafting through CytoSorbents’ (NASDAQ:CTSO) corridors this quarter. The company just nudged into positive territory with its operating cash flow, which, let’s be honest, is like finding a nugget of gold amid last year’s rubble of losses. With $43,000 of positive operating cash flow in a world...

Continue Reading
Toys"R"Us Rolls Out 160 U.S. Stores, NYC Celebration

Updated Category News Views 22

Rebuilding the Toy Empire After a rough few years, Toys"R"Us is clawing its way back into the hearts—and wallets—of American shoppers. With 160+ new standalone stores popping up like mushrooms after rain, these guys aren't just playing games. This is a strategic move to reestablish their presence in the retail landscape just before the holiday shopping frenzy kicks...

Continue Reading
Duke Energy's Cooling Tips Amid Florida Cold Front

Updated Category News Views 54

Weather Whiplash in Florida Prompts Energy Tips Florida's residents are in for a gust of chilly air as a cold front sweeps across the state, sending temperatures plummeting from the balmy 80s to brisk 30s and 40s in northern pockets. Central Florida ain't missing out on the chill either, expecting to dip a good dozen degrees below its usual seasonal warmth. Heads up,...

Continue Reading
NueSynergy Secures Top Spot in HSA Provider Rankings

Updated Category News Views 79

NueSynergy Earns its Stripes in 2026 It seems these days, healthcare costs are rising faster than you can say 'deductible.' In this chaotic landscape, a good HSA provider is worth its weight in gold. Enter NueSynergy, whose efforts have once again been acknowledged by Morningstar, a big name in the world of investment research. What Sets NueSynergy Apart? NueSynergy isn't...

Continue Reading
Daniel Wellington's 2026 Holiday Gift Guide Highlights

Updated Category News Views 56

Personalized Gifts for the Holidays You ever try picking out a gift that screams 'I nailed it'? Daniel Wellington gets it, and this year's Holiday Gift Guide is their way of handing you the solution on a silver platter. It’s all about refining your choices to match the style and personality that make each person unique. Forget the generic socks; this guide is laying out...

Continue Reading
Revving Up: TIER IV and Komatsu's Bold Auto Move

Updated Category News Views 79

Steering Toward a Driverless Future When you think of technology leaders, dump trucks might not be the first thing that comes to mind. But here we are, with TIER IV and Komatsu sparking up a collaboration to drive their heavy-duty fleet straight into the future. We're talking autonomous driving systems for three brawny dump truck models—the HD785, HD605, and...

Continue Reading

Top 5 Most Recently Viewed Articles

Investigation Launched into National HealthCare Corporation by Kaskela Law

Updated Category News Views 163

Kaskela Law LLC Announces Investigation Kaskela Law LLC has recently launched an investigation into National HealthCare Corporation (NYSE: NHC) on behalf of its shareholders. This inquiry seeks to determine if the company or its executives have violated securities laws or breached their fiduciary duties in light of recent corporate actions. Investigation Objectives The...

Continue Reading
Max Stock Limited Observes Significant Shareholding Changes

Updated Category News Views 124

Max Stock Limited Reports Changes in Share Holdings Max Stock Limited (TASE: MAXO) has announced a noteworthy increase in the shareholdings of Migdal Insurance Company Ltd., along with its affiliate firms. This increase was highlighted in a company release, indicating that as a result of recent trading activity, these entities have expanded their ownership of Max Stock's...

Continue Reading
Tucows Appoints Diverse Board Members to Drive Innovation Forward

Updated Category News Views 273

Tucows Welcomes a New Board of Directors to Propel Forward Tucows Inc. (NASDAQ: TCX) has made significant strides in enhancing its leadership by electing eight new directors to its Board of Directors. This change comes as the company seeks to amplify its growth trajectory and foster innovation. The newly formed board comprises individuals with diverse backgrounds in...

Continue Reading
Rapid Growth of Solar Container Market Expected by 2030

Updated Category News Views 281

Exploring the Solar Container Market's Future The solar container market is on a promising trajectory, with projections estimating a rise to approximately USD 0.83 billion by 2030, growing from USD 0.29 billion in 2025. This growth corresponds to an impressive compound annual growth rate (CAGR) of 23.8% throughout the forecast period. Various factors are at play, pushing...

Continue Reading
Jazz Pharmaceuticals Reports Impressive Q3 2025 Growth

Updated Category News Views 232

Jazz Pharmaceuticals Achieves Significant Q3 2025 Growth In a remarkable quarter, Jazz Pharmaceuticals plc (NASDAQ: JAZZ) reported impressive financial results for the third quarter of 2025. This period marked not only robust revenue growth but also significant advancements in their product portfolio, indicating a bright future for the company. Key Product Milestones One...

Continue Reading